Skip to main content
AMGN logo
AMGN
(NASDAQ)
Amgen Inc.
$393.17-- (--)
Loading... - Market loading

Amgen Inc. (AMGN) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Amgen Inc. stock.

Analyst Consensus Rating

Investment consensus from 31 professional research analysts

Consensus Rating

Hold
Based on 31 unique analysts
(45 total ratings in last 90 days)
Very High Confidence7.0:1 Buy/Sell

Average Price Target

$393.25
0.02% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest AMGN Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
NASDAQ:AMGN
Investing.com
HoldInitiates Coverage
-
Urmimala Biswas
Zacks Equity Research
HoldInitiates Coverage
-
Kinjel Shah
Zacks Equity Research
HoldInitiates Coverage
-
Aparajita Dutta
Zacks Equity Research
BuyInitiates Coverage
-
Salim Syed
Mizuho
HoldMaintains
$303.00 $352.00
Emily Field
Barclays
HoldMaintains
$360.00 $380.00
Geoff Meacham
Citi
HoldMaintains
$345.00 $405.00
Vamil Divan
Guggenheim
HoldMaintains
$343.00 $388.00
Chris Schott
JP Morgan
HoldMaintains
$350.00
Google Drug Manufacturers - General
TipRanks - Google
BuyReiterates
$424.00 $449.00
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
BuyReiterates
$426.00 $450.00
Anthropic Drug Manufacturers - General
TipRanks - Anthropic
HoldReiterates
$393.00 $411.00
DeepSeek Drug Manufacturers - General
TipRanks - DeepSeek
BuyReiterates
$418.00 $456.00
xAi Drug Manufacturers - General
TipRanks - xAI
BuyReiterates
$429.00 $452.00
DefenseMania
StockTwits
BuyInitiates Coverage
-
Gary Nachman
Canaccord Genuity
HoldMaintains
$366.00 $384.00
OpenAI Drug Manufacturers - General
TipRanks - OpenAI
BuyReiterates
$416.00 $439.00
Courtney Breen
Bernstein
HoldMaintains
$335.00 $345.00
Salveen Richter
Goldman Sachs
BuyMaintains
$427.00 $450.00
Tazeen Ahmad
BofA Securities
SellReiterates
$312.00 $317.00
Michael Yee
UBS
BuyMaintains
$420.00 $440.00
Brian Skorney
Baird
SellMaintains
$215.00 $230.00
Jay Olson
Oppenheimer
BuyMaintains
$400.00 $450.00
Luca Issi
RBC Capital
BuyMaintains
$370.00 $400.00
Sundeep Ganoria
Zacks Equity Research
BuyInitiates Coverage
-
Tazeen Ahmad
BofA Securities
SellReiterates
$307.00 $312.00
Evan Seigerman
BMO Capital
BuyMaintains
$400.00
Michael Yee
UBS
BuyReiterates
$400.00 $420.00
Mohit Bansal
Wells Fargo
HoldMaintains
$390.00
Vamil Divan
Guggenheim
HoldMaintains
$340.00 $343.00
Terence Flynn
Morgan Stanley
HoldMaintains
$340.00 $333.00
Gregory Renza
Truist
HoldMaintains
$327.00 $340.00
Luca Issi
RBC Capital
BuyMaintains
$370.00
Google Drug Manufacturers - General
TipRanks - Google
BuyReiterates
$412.00
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
BuyReiterates
$413.00
Anthropic Drug Manufacturers - General
TipRanks - Anthropic
HoldReiterates
$382.00
DeepSeek Drug Manufacturers - General
TipRanks - DeepSeek
HoldReiterates
$406.00
Evan Seigerman
BMO Capital
BuyMaintains
$400.00
David Amsellem
Piper Sandler
BuyReiterates
$427.00
Salim Syed
Mizuho
HoldMaintains
$303.00
Salim Syed
Mizuho
HoldMaintains
$303.00
Luca Issi
RBC Capital
BuyReiterates
$370.00
Salim Syed
Mizuho
HoldMaintains
$295.00 $303.00
David Amsellem
Piper Sandler
BuyReiterates
$427.00

Frequently Asked Questions

What is the analyst consensus rating for AMGN?

The analyst consensus rating for AMGN is "Hold" based on 31 analyst recommendations.

What is the average price target for AMGN?

The average 12-month price target for AMGN is $393.25, representing an upside of 0.0% from the current price of $393.17.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.